Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter?

Molecular Biology Reports

Volumn 38, Issue 3, 2011, Pages 1469-1474

  Ayşegül, Bayramoglu ^a   Veysi, Gunes Hasan ^a   Muzaffer, Metintas ^a   Irfan, Degirmenci ^a   Azra, Akin ^a   Hulyam, Kurt ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Lung cancer; MMP 2 gene C1306T polymorphism; Plasma MMP 2 enzyme activity

Indexed keywords

ASBESTOS; CYTOSINE; GELATINASE A; GENOMIC DNA; THYMINE;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE MARKER; ELECTROPHORESIS; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; ROC CURVE;

EID: 79951580862     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0253-5     Document Type: Article

References (26)

1. J Rollin S Ŕeginaa P Vourc'h S Iochmanna C Bĺechet P Reverdiau Y Gruel 2007 Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer Lung Cancer 56 273 280 17208328 10.1016/j.lungcan.2006.11.021 (Pubitemid 46591988)
2. S Apakkan D Özmen O BayIndIr 2001 Metalloproteinazlar, Inhibitörleri ve ilişkili Fizyolojik ve Patolojik Durumlar Turkiye Klinikleri J Med Sci 21 332 342
3. S Gerhards K Jung F KoenIg D Daniltchenco S Hauptmann D Schnorr S LoenIng 2001 Excretion of matrix metalloproteinases 2 And 9 in urine is associated with a high stage and grade of bladder carcinoma Urology 57 675 679 1:STN:280:DC%2BD3M3ms1Wqtw%3D%3D 11306379 10.1016/S0090-4295(00)01087-6
4. DE Kleiner WG Stetler-Stevenson 1999 Matrix metalloproteinases and metastasis Cancer Chemother Pharmacol 43 42 51 10.1007/s002800051097
5. M Duffy M Teresa A Hill E Mcdermott 2000 Metalloproteinases: role in breast carcinogenesis, invasion and metastasis Breast Cancer Res 2 252 257 1:CAS:528:DC%2BD3cXlvFOgs7Y%3D 11250717 10.1186/bcr65 (Pubitemid 32223594)
6. P Brown 1998 Matrix metalloproteinase inhibitors Breast Cancer Res Treat 52 125 136 1:STN:280:DyaK1M7mtl2lsg%3D%3D 10066077 10.1023/A:1006119319695 (Pubitemid 29056090)
7. SM Ellerbroek SM Stack 1999 Membrane associated matrix metalloproteinases in metastasis Bioessays 21 940 949 1:STN:280:DyaK1MvkslChug%3D%3D 10517867 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.0.CO;2-J (Pubitemid 29530603)
8. S Chakraborti M Mandal S Das A Mandal T Chakraborti 2003 Regulation of matrix metalloproteinases: an overview Mol Cell Biochem 253 269 285 1:CAS:528:DC%2BD3sXnslSgsbc%3D 14619979 10.1023/A:1026028303196 (Pubitemid 37321735)
9. R Visse H Nagase 2003 Matrix metalloproteinases and tissue inhibitors of metalloproteinases, structure, function and biochemistry Circ Res 92 827 839 1:CAS:528:DC%2BD3sXjtFWqu7c%3D 12730128 10.1161/01.RES.0000070112.80711.3D (Pubitemid 36542523)
10. LM Coussens B Fingleton LM Matrisian 2002 Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2387 2392 1:CAS:528:DC%2BD38XisFSmtb0%3D 11923519 10.1126/science.1067100 (Pubitemid 34270240)
11. P Vihinen VM Kahari 2002 Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99 157 166 1:CAS:528: DC%2BD38XivFyrsr4%3D 11979428 10.1002/ijc.10329 (Pubitemid 34309470)
12. S Chakrabarti P Kamala 2005 Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology Exp Lung Cancer 31 599 621 1:CAS:528:DC%2BD2MXls1Sksrw%3D (Pubitemid 40967244)
13. F Grieu WQ Li B Lacopetta 2004 Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype Breast Cancer Res Treat 88 197 204 1:CAS:528:DC%2BD2MXht1Kjt70%3D 15609121 10.1007/s10549-004-0595-6 (Pubitemid 40137297)
14. A Vasku M Goldbergova LI Holla L Siskova L Groch M Beranek S Tschöplova V Znojil J Vácha 2004 A haplotype constituted of four MMP-2 promoter polymorphisms (-1575 G/A, -1306 C/T, -790 T/G and -735 C/T) is associated with coronary triple-vessel disease Matrix Biol 22 585 591 1:CAS:528:DC%2BD2cXhslChs7k%3D 14996438 10.1016/j.matbio.2003.10.004 (Pubitemid 38283782)
15. E Xu M Lai B Lv X Xing Q Huang X Xia 2004 A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer Biochem Biophys Res Commun 324 999 1003 1:CAS:528: DC%2BD2cXos1Kltr0%3D 15485653 10.1016/j.bbrc.2004.09.150 (Pubitemid 39361607)
16. Y Zhou C Yu X Miao W Tan G Liang P Xiong T Sun D Lin 2004 Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 gene Carcinogenesis 25 399 404 1:CAS:528: DC%2BD2cXhslWks7Y%3D 14604886 10.1093/carcin/bgh020 (Pubitemid 38344407)
17. C Yu K Pan D Xing G Liang W Tan L Zhang D Lin 2002 Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer Cancer Res 62 6430 6433 1:CAS:528:DC%2BD38XovFOlurY%3D 12438229 (Pubitemid 35364100)
18. C Yu Y Zhou X Miao P Xiong W Tan D Lin 2004 Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer Cancer Res 64 7622 7628 1:CAS:528: DC%2BD2cXosFymsrw%3D 15492291 10.1158/0008-5472.CAN-04-1521 (Pubitemid 39372109)
19. N Lamblin C Bauters X Herman t JM Lablanche N Helbecque P Amouyel 2002 Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease J Am Coll Cardiol 40 43 48 1:CAS:528:DC%2BD38Xls1Cqsrs%3D 12103254 10.1016/S0735-1097(02)01909-5 (Pubitemid 34701375)
20. A Staack S Badendieck D Schnorr S Loening K Jung 2006 Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder BMC Urol 6 1 12 10.1186/1471-2490-6-19 (Pubitemid 44367986)
21. A Augustine R Harris EL Wynder 1989 Compensation as a risk factor for lung cancer in smokers who switch from nonfilter to filter cigarettes Am J Public Health 79 188 191 1:STN:280:DyaL1M7hs1eksQ%3D%3D 2913838 10.2105/AJPH.79.2.188 (Pubitemid 19052365)
22. CF Mountain 1997 Revision in the international system for staging lung cancer Chest 111 1710 1717 1:STN:280:DyaK2szjtVOguw%3D%3D 9187198 10.1378/chest.111.6.1710 (Pubitemid 27260107)
23. AF Gazdar M Thun 2007 Lung cancer, smoke exposure, and sex J Clin Oncol 25 469 471 17290053 10.1200/JCO.2006.09.4623 (Pubitemid 350002950)
24. Y Zhou C Yu X Miao Y Wang W Tan T Sun X Zhang P Xiong D Lin 2005 Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility Carcinogenesis 26 1117 1121 1:CAS:528:DC%2BD2MXkvVShtLc%3D 15731163 10.1093/carcin/bgi057 (Pubitemid 41214305)
25. MG Tutton M George SA Eccles S Burton J SwIft M AbulafI 2003 Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients Int J Cancer 107 541 550 1:CAS:528:DC%2BD3sXoslequ7s%3D 14520690 10.1002/ijc.11436 (Pubitemid 37296113)
26. S Won Lee KE Song DS Shin SM Ahn ES Ha DJ Kim MS Nam KW Lee 2005 Alterations in peripheral blood levels of TIMP-1, MMP-2 and MMP-9 in patients with type-2 diabetes Diabetes Res Clin Pract 69 175 179 10.1016/j.diabres.2004. 12.010 (Pubitemid 40943483)